- Friedreich’s ataxia chosen as first neurological indication - Reported Phase 1b data for lead immuno-oncology candidate in solid tumors -Development partnership with Allergan in hair loss disorders - Cash and short-term investments on Dec. 31, 2019 of $110.8 million Exicure, Inc. (NASDAQ:XCUR), the pioneer in gene regulatory and immunotherapeutic… Read More..

Demand and growth for Hooters Spirits continues with rollouts into more Hooters restaurants Multi-year deal with Chase Elliott solidifies another milestone for Iconic and Hooters   AMITYVILLE, NY, March 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Iconic Brands, Inc. (ICNB) (“Iconic” or the “Company”), is pleased to announce today… Read More..

FRAMINGHAM, Mass., March 02, 2020 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a presenting company during the 2020 LD Micro Virtual Investor Conference. The conference is being held on… Read More..